Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: A randomized controlled trial

JAMA

Volumn 279, Issue 19, 1998, Pages 1537-1541

  Zimmerli, Werner ^a   Widmer, Andreas F ^a   Blatter, Marianne ^a   Frei, R ^a   Ochsner, Peter E ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Chirurgische Klinik Kantonsspital Liestal   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CIPROFLOXACIN; FLUCLOXACILLIN; RIFAMPICIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; ORTHOPEDIC SURGERY; OSTEOMYELITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032550664     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.19.1537     Document Type: Article

References (37)

1. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med. 1997;326:999-1007.
2. Schutzer SF, Harris WH. Deep-wound infection after total hip replacement under contemporary aseptic conditions. J Bone Joint SurgAm. 1988;70: 724-727.
3. NIH Consensus Development Panel on Total Hip Replacement. Total hip replacement. JAMA. 1995; 273:1950-1956.
4. Garvin KL, Hanssen AD. Infection after total hip arthroplasty. J Bone Joint Surg Am. 1995;77:1576-1588.
5. Zych GA, Hutson JJ. Diagnosis and management of infection after tibial intramedullary nailing. Clin Orthop. 1995;315:153-162.
6. Gustilo RB, Merkow RL, Templeman D. The management of open fractures. J Bone Joint Surg Am. 1990;72:299-304.
7. Morscher E, Herzog R, Bapst R, Zimmerli W. Management of infected hip arthroplasty. Orthop Int. 1995;3:343-351.
8. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. J Bone Joint Surg Am. 1996;78:512-523.
9. Wolfe SW, Figgie MP, Inglis AE, Bohn WW, Ranawat CS. Management of infection about total elbow prostheses. J Bone Joint Surg Am. 1990;72:198-212.
10. Schoifet SD, Morrey BF. Treatment of infection after total knee arthroplasty by débridement with retention of the components. J Bone Joint Surg Am. 1990;72:1383-1390.
11. Rasul AT, Tsukayama D, Gustilo RB. Effect of time on onset and depth of infection on the outcome of total knee arthroplasty infections. Clin Orthop. 1991;273:98-103.
12. Burger RR, Basch T, Hopson CN. Implant salvage in infected total knee arthroplasty. Clin Orthop. 1991;273:105-111.
13. Hartman MB, Fehring TK, Jordan L, Norton HJ. Periprosthetic knee sepsis: the role of irrigation and debridement. Clin Orthop. 1991;273:113-118.
14. Tsukayama DT, Wicklund B, Gustilo RB. Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics. 1991;14:841-844.
15. Wilson MG, Kelley K, Thornhill TS. Infection as a complication of total knee-replacement arthroplasty. J Bone Joint Surg Am. 1990;72:878-883.
16. Brandt CM, Sistrunk WW, Duffy MC, et al. Staphylococcus aureus prosthetic infection treated with debridement and prosthesis retention. Clin Infect Dis. 1997;24:914-919.
17. McGraw JM, Lim E. Treatment of open tibial shaft fractures: external fixation and secondary intramedullary nailing. J Bone Joint Surg Am. 1988; 70:900-911.
18. Ochsner PE, Brunazzi MG. Intramedullary reaming and soft tissue procedures in treatment of chronic osteomyelitis of long bones. Orthopedics. 1994;17:433-440.
19. Salvati EA, Snail RD, Brause BD, Pellicci PM. Infections associated with orthopedic devices. In: Sugarman B, Young EJ, eds. Infections Associated With Prosthetic Devices. Boca Raton, Fla: CRC Press Inc; 1984:181-218.
20. Dellamonica P, Etesse-Carsenti H, Bernard E, Mondain V, Durant J, Argenson C. Pefloxacin in the treatment of bone infections associated with foreign material. J Antimicrob Chemother. 1990;26(suppl B):199-205.
21. Steckelberg JM, Osmon DR. Prosthetic joint infections. In: Bisno AL, Waldvogel FA, eds. Infections Associated With Indwelling Medical Devices. 2nd ed. Washington, DC: ASM Press; 1994:259-290.
22. Tshefu K, Zimmerli W, Waldvogel FA. Short-term rifampin administration in the prevention/ eradication of foreign body infection. Rev Infect Dis. 1983;5(suppl 3):S474-S480.
23. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign-body infections. J Infect Dis. 1990;162:96-102.
24. Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother. 1994;33:959-967.
25. Blaser J, Vergères P, Widmer AF, Zimmerli W. In-vivo verification of an in-vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother. 1995;39:1134-1139.
26. Widmer AF, Gächter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis. 1992;14:1251-1253.
27. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother. 1993; 37:1214-1218.
28. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 6th ed. Washington, DC: ASM Press: 1995.
29. Pfaller MA, Hollis RJ, Sader HS. PFGE analysis of chromosomal restriction fragments. In: Isenberg HD, ed. Clinical Microbiology Procedures Handbook: Supplement 1. Washington, DC: ASM Press; 1992:1-12.
30. Dupont WD, Plummer WDJ. Power and sample size calculations: a review and computer program. Control Clin Trial. 1990;11:116-128.
31. Cox DR, Oakes D. Analysis of Survival Data. London, England: Chapman & Hall; 1990.
32. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection: evidence for a local granulocyte defect. J Clin Invest. 1984;73:1191-1200.
33. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987;237:1588-1595.
34. Gristina AG. Biofilms and chronic bacterial infections. Clin Microbiol Newslett. 1994;16:171-176.
35. Dworkin RJ, Sande MA, Lee BL, Chambers HF. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampin. Lancet. 1989;2:1071-1073.
36. Heldman AW, Hartert TV, Ray CR, et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med. 1996;101:68-76.
37. Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. N Engl J Med. 1991;324:384-394.